4.7 Article

CXC chemokines in angiogenesis related to pulmonary fibrosis

Journal

CHEST
Volume 122, Issue 6, Pages 298S-301S

Publisher

AMER COLL CHEST PHYSICIANS
DOI: 10.1378/chest.122.6_suppl.298S

Keywords

angiogenesis; chemokine; fibrosis

Funding

  1. NCI NIH HHS [P50 CA90388, CA87879] Funding Source: Medline
  2. NHLBI NIH HHS [HL66027, HL03906, HL04493, P01 HL67665] Funding Source: Medline

Ask authors/readers for more resources

Angiogenesis, defined as the growth of new capillaries from preexisting vessels, is a pervasive biological phenomenon that is at the core of many physiologic and pathologic processes. An opposing balance of angiogenic and angiostatic factors regulates angiogenesis. Examples of physiologic processes that depend on angiogenesis include embryogenesis, wound repair, and the ovarian/menstrual cycle. In contrast, chronic inflammation associated with chronic fibroproliferative disorders as well as growth and metastasis of solid tumors are associated with aberrant angiogenesis. CXC chemokines comprise a unique cytokine family that contains members that exhibit on a structural/functional basis either angiogenic or angiostatic biological activity. In this review, we will discuss the role of CXC chemokines and angiogenesis in pulmonary fibrosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available